BBI insider filings
Brickell Biotech, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-05-17. Screen BBI transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BBI between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Brickell Biotech, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-05-17 | 4 | VERU DENNISON T — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2022-05-17 | 4 | SAMANT VIJAY B — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2022-05-17 | 4 | LYONS GARY A — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2022-05-17 | 4 | HARDY REGINALD L — CHAIRMAN OF THE BOARD, Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Chadha Deepak — Chief Research & Dev. Officer | Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Breton Jose — Chief Accounting Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Brown Robert Busard — Chief Executive Officer, Director | Grant/award (A): 1,100,000 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Sklawer Andrew D — COO and Secretary | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | McAvoy David R. — General Counsel and CCO | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Luchi Monica E. — Chief Medical Officer | Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | MARCHIO ALBERT N II — Chief Financial Officer | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-02-25 | 4 | HARDY REGINALD L — CHAIRMAN OF THE BOARD, Director | Tax withholding (F): 15,180 @ $0.23 | EDGAR |
| 2021-09-03 | 4 | Luchi Monica E. — Chief Medical Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2021-07-27 | 4 | McAvoy David R. — General Counsel and CCO | Purchase (P): 18,124 @ $0.67 | EDGAR |
| 2021-07-27 | 4 | HARDY REGINALD L — CHAIRMAN OF THE BOARD, Director | Purchase (P): 100,000 @ $0.66 · Purchase (P): 100,000 @ $0.67 | EDGAR |
| 2021-06-14 | 4 | Chadha Deepak — Chief Research & Dev. Officer | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Breton Jose — Chief Accounting Officer | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Brown Robert Busard — Chief Executive Officer, Director | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Sklawer Andrew D — COO and Secretary | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | McAvoy David R. — General Counsel and CCO | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | VERU DENNISON T — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | SAMANT VIJAY B — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | MARCHIO ALBERT N II — Chief Financial Officer | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | LYONS GARY A — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | HARDY REGINALD L — CHAIRMAN OF THE BOARD, Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-05-19 | 4 | Chadha Deepak — Chief Research & Dev. Officer | Purchase (P): 2,700 @ $0.82 · Purchase (P): 12,500 @ $0.83 | EDGAR |
| 2021-05-19 | 4 | Sklawer Andrew D — COO and Secretary | Purchase (P): 15,375 @ $0.80 | EDGAR |
| 2021-05-19 | 4 | McAvoy David R. — General Counsel and CCO | Purchase (P): 18,622 @ $0.80 · Purchase (P): 7,980 @ $0.80 | EDGAR |
| 2021-03-17 | 4 | Chadha Deepak — Chief Research & Dev. Officer | Option exercise (M): 25,000 · Tax withholding (F): 8,750 @ $1.14 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2021-03-17 | 4 | Breton Jose — Chief Accounting Officer | Option exercise (M): 15,000 · Tax withholding (F): 5,250 @ $1.14 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2021-03-17 | 4 | Brown Robert Busard — Chief Executive Officer, Director | Purchase (P): 100,000 @ $1.18 | EDGAR |
| 2021-03-17 | 4 | Sklawer Andrew D — COO and Secretary | Option exercise (M): 20,000 · Tax withholding (F): 7,000 @ $1.14 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2021-03-17 | 4 | McAvoy David R. — General Counsel and CCO | Option exercise (M): 25,000 · Tax withholding (F): 8,750 @ $1.14 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | SAMANT VIJAY B — Director | Tax withholding (F): 4,408 @ $0.78 | EDGAR |
| 2021-01-05 | 4 | LYONS GARY A — Director | Tax withholding (F): 5,967 @ $0.78 | EDGAR |
| 2021-01-05 | 4 | HARDY REGINALD L — Chairman of the Board, Director | Tax withholding (F): 4,873 @ $0.78 · Grant/award (A): 47,435 @ $0.78 | EDGAR |
| 2020-09-21 | 4 | McAvoy David R. — General Counsel and CCO | Purchase (P): 16,526 @ $0.83 · Purchase (P): 6,000 @ $0.84 | EDGAR |
| 2020-09-17 | 4 | McAvoy David R. — General Counsel and CCO | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | VERU DENNISON T — Director | Gift (G): 19,642 @ $0 · Grant/award (A): 13,580 @ $0.81 · Purchase (P): 15,355 @ $0.81 · Purchase (P): 14,645 @ $0.80 · Gift (G): 19,642 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | SAMANT VIJAY B — Director | Grant/award (A): 10,493 @ $0.81 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | LYONS GARY A — Director | Grant/award (A): 11,934 @ $0.81 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | HARDY REGINALD L — Chairman of the Board, Director | Grant/award (A): 15,226 @ $0.81 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2020-09-16 | 4 | Chadha Deepak — Chief Research & Dev. Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2020-09-16 | 4 | Breton Jose — Chief Accounting Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2020-09-16 | 4 | Brown Robert Busard — Chief Executive Officer, Director | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2020-09-16 | 4 | Sklawer Andrew D — COO and Secretary | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2020-09-02 | 4 | VERU DENNISON T — Director | Option exercise (M): 788 · Option exercise (M): 788 (derivative) @ $0 | EDGAR |
| 2020-09-02 | 4 | SAMANT VIJAY B — Director | Option exercise (M): 609 · Tax withholding (F): 256 @ $0.94 · Tax withholding (F): 6,375 @ $0.94 · Option exercise (M): 609 (derivative) @ $0 | EDGAR |
| 2020-09-02 | 4 | LYONS GARY A — Director | Option exercise (M): 692 · Tax withholding (F): 346 @ $0.94 · Tax withholding (F): 8,631 @ $0.94 · Option exercise (M): 692 (derivative) @ $0 | EDGAR |
| 2020-09-02 | 4 | HARDY REGINALD L — Chairman of the Board, Director | Option exercise (M): 883 · Tax withholding (F): 283 @ $0.94 · Tax withholding (F): 7,048 @ $0.94 · Option exercise (M): 883 (derivative) @ $0 | EDGAR |
Recent 8-K events — Brickell Biotech, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-03-07 | 8-K | 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-03 | 8-K | 1.02 — Termination of a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-27 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-18 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-15 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BBI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs